Back to Search Start Over

Prevalence evolution of SARS-CoV-2 infection in the city of São Paulo, 2020–2021

Authors :
José Olimpio Moura de Albuquerque
Gabriela Akemi Kamioka
Geraldine Madalosso
Selma Anequini Costa
Paula Bisordi Ferreira
Francisco Alberto Pino
Ana Paula Sayuri Sato
Ana Carolina Aguiar de Carvalho
Ana Beatriz Pagliaro Amorim
Caroline Cotrim Aires
Ana Paula Arruda Geraldes Kataoka
Elisa San Martin Mouriz Savani
Thirsa Alvares Franco Bessa
Breno Souza de Aguiar
Marcelo Antunes Failla
Edson Aparecido dos Santos
Edjane Maria Torreão Brito
Maria Cristina Honório dos Santos
Solange Maria Saboia e Silva
Luiz Artur Vieira Caldeira
Luiz Carlos Zamarco
Sandra Maria Sabino Fonseca
Marcia Maria de Cerqueira Lima
Ivanilda Argenau Marques
Fabiana Érica Vilanova da Silva
Paula Regina Glasser
Patrícia Carla Piragibe Ramos Burihan
Cinthya Luzia Cavazzana
Debora Silva de Mello
Alessandra Cristina Guedes Pellini
Fernando Yoshiki Nishio
Fernanda Miyashiro Kian
Elza de Santana Braga
Nilza Maria Piassi Bertelli
Wagner Fracini
Marcelo Dell Áquila Gonçalves
Paulete Secco Zular
Regiane de Santana Piva
Eduardo Masi
Source :
Revista de Saúde Pública, Vol 55 (2021)
Publication Year :
2021
Publisher :
Universidade de São Paulo, 2021.

Abstract

ABSTRACT OBJECTIVE To estimate the evolution of the prevalence of SARS-CoV-2 virus infection among residents aged 18 years or over in the municipality of São Paulo. METHODS This is a population-based household survey conducted every 15 days, between June and September 2020, and January and February 2021. In total, the study comprised 11 phases. The presence of antibodies against SARS-CoV-2 was identified in venous blood using a lateral flow test, Wondfo Biotech. In the last phase, the researchers combined it with an immunoenzymatic test, Euroimmun. The participants also answered a semi-structured questionnaire on sociodemographic and economic factors, and on social distancing measures. Prevalence estimates and the 95% confidence interval were estimated according to regions, Human Development Index, sex, age group, ethnicity, education, income, and variables associated with risk or prevention of infection. To compare the frequencies among the categories of each variable, the chi-square test with Rao-Scott correction was used, considering a significance level of 5%. RESULTS In total, 23,397 individuals were interviewed and had their samples collected. The estimated prevalence of antibodies against SARS-CoV-2 ranged from 9.7% (95%CI: 7.9–11.8%) to 25.0% (95%CI: 21.7–28.7). The prevalence of individuals with antibodies against the virus was higher among black and brown people, people with lower schooling and income, and among residents of regions with lower Human Development Index. The lowest prevalences were associated with recommended measures of disease protection. The proportion of asymptomatic infection was 45.1%. CONCLUSION The estimated prevalence of the infection was lower than the cumulative incidence variation, except for the last phase of the study. The differences in prevalence estimates observed among subpopulations showed social inequality as a risk of infection. The lower prevalence observed among those who could follow prevention measures reinforce the need to maintain social distancing measures as a way to prevent SARS-CoV-2 infection.

Details

Language :
English, Spanish; Castilian, Portuguese
ISSN :
15188787
Volume :
55
Database :
Directory of Open Access Journals
Journal :
Revista de Saúde Pública
Publication Type :
Academic Journal
Accession number :
edsdoj.1645f0d9198946f39713ca800814ae8b
Document Type :
article
Full Text :
https://doi.org/10.11606/s1518-8787.2021055003970